A23K20/168

Compositions for oral administration to animals, processes for obtaining the same and the uses thereof
11103524 · 2021-08-31 · ·

The present invention concerns a solid, palatable composition and its preparation process which, relative to the total weight of the composition, comprises: 5 to 30%, preferably 8 to 20% by weight of at least one fat chosen from among a liquid oil, a fat, wax or mixture thereof, the liquid oil not to represent more than 8% by weight of the composition; 0.001 to 85% by weight of at least one active substance; and 20 to 95%, preferably 40 to 70% by weight of at least one palatable material,
for use thereof as medicinal product, nutraceutical or food supplement, for oral administration to mammals, except man, in particular for domestic animals such as dogs, cats or horses. The said solid composition is obtained by mixing the components, vaporising the fats, calibrating the dry, fluid granular material and compressing the granular material in a stock cube press.

Compositions for oral administration to animals, processes for obtaining the same and the uses thereof
11103524 · 2021-08-31 · ·

The present invention concerns a solid, palatable composition and its preparation process which, relative to the total weight of the composition, comprises: 5 to 30%, preferably 8 to 20% by weight of at least one fat chosen from among a liquid oil, a fat, wax or mixture thereof, the liquid oil not to represent more than 8% by weight of the composition; 0.001 to 85% by weight of at least one active substance; and 20 to 95%, preferably 40 to 70% by weight of at least one palatable material,
for use thereof as medicinal product, nutraceutical or food supplement, for oral administration to mammals, except man, in particular for domestic animals such as dogs, cats or horses. The said solid composition is obtained by mixing the components, vaporising the fats, calibrating the dry, fluid granular material and compressing the granular material in a stock cube press.

Process for treating arabinoxylan-containing substrate

The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.

Process for treating arabinoxylan-containing substrate

The present invention relates to isolated polypeptides having alpha-L-arabinofuranosidase activity and isolated nucleic acid sequences encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.

Use of compounds that are able to increase the serum IGF-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced IGF-1 serum level in humans and animals

The present disclosure relates to the use of one or more compounds that are capable of increasing the serum level of insulin-like growth factor 1 (IGF-1) for the preparation of a therapeutical composition, in particular, in the form of a food supplement, for the treatment of subjects suffering from serious fatigue and exhausting symptoms, burn-out and chronic fatigue syndrome. The same composition can also be used by patients suffering from depression, Alzheimer disease, irritated bowel syndrome, osteoporosis, type 2 diabetes, or for anti-aging, immune therapy and recovery after exercise. The composition also has a use in veterinary applications for increasing the growth and immunity in animals.

Use of compounds that are able to increase the serum IGF-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced IGF-1 serum level in humans and animals

The present disclosure relates to the use of one or more compounds that are capable of increasing the serum level of insulin-like growth factor 1 (IGF-1) for the preparation of a therapeutical composition, in particular, in the form of a food supplement, for the treatment of subjects suffering from serious fatigue and exhausting symptoms, burn-out and chronic fatigue syndrome. The same composition can also be used by patients suffering from depression, Alzheimer disease, irritated bowel syndrome, osteoporosis, type 2 diabetes, or for anti-aging, immune therapy and recovery after exercise. The composition also has a use in veterinary applications for increasing the growth and immunity in animals.

METHODS TO INCREASE SILAGE QUALITY IN CROPS
20200187527 · 2020-06-18 ·

The present invention is directed to methods for increasing the quality of crop plant silage that are consumed by milk and meat-producing animals. The methods involve the following steps: 1) treating plants with a gibberellin; 2) producing silage from the plants treated according to step 1); and 3) feeding silage produced according to step 2) to milk and/or meat-producing animals. Applicants' methods result in higher quality meat from the meat-producing animals and increased milk from the milk-producing animals.

METHODS TO INCREASE SILAGE QUALITY IN CROPS
20200187527 · 2020-06-18 ·

The present invention is directed to methods for increasing the quality of crop plant silage that are consumed by milk and meat-producing animals. The methods involve the following steps: 1) treating plants with a gibberellin; 2) producing silage from the plants treated according to step 1); and 3) feeding silage produced according to step 2) to milk and/or meat-producing animals. Applicants' methods result in higher quality meat from the meat-producing animals and increased milk from the milk-producing animals.

HUMAN DIET EQUIVALENT ANIMAL FEED
20200029598 · 2020-01-30 ·

The present invention provides methods for creating a human diet equivalent for use in animal feed, animal feed compositions comprising a human diet equivalent, and methods for processing human foods into an animal feed ration.

HUMAN DIET EQUIVALENT ANIMAL FEED
20200029598 · 2020-01-30 ·

The present invention provides methods for creating a human diet equivalent for use in animal feed, animal feed compositions comprising a human diet equivalent, and methods for processing human foods into an animal feed ration.